Mesa Laboratories, Inc. (NASDAQ:MLAB) Stock Position Lifted by Texas Permanent School Fund

Texas Permanent School Fund boosted its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLABGet Rating) by 2.3% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,806 shares of the medical instruments supplier’s stock after purchasing an additional 87 shares during the period. Texas Permanent School Fund’s holdings in Mesa Laboratories were worth $776,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. BlackRock Inc. grew its position in Mesa Laboratories by 0.4% during the first quarter. BlackRock Inc. now owns 924,948 shares of the medical instruments supplier’s stock valued at $235,751,000 after purchasing an additional 4,061 shares in the last quarter. Royce & Associates LP lifted its stake in Mesa Laboratories by 4.1% in the first quarter. Royce & Associates LP now owns 356,643 shares of the medical instruments supplier’s stock valued at $90,901,000 after acquiring an additional 13,885 shares during the last quarter. Vanguard Group Inc. lifted its stake in Mesa Laboratories by 1.3% in the first quarter. Vanguard Group Inc. now owns 341,492 shares of the medical instruments supplier’s stock valued at $87,040,000 after acquiring an additional 4,464 shares during the last quarter. Invesco Ltd. lifted its stake in Mesa Laboratories by 0.7% in the first quarter. Invesco Ltd. now owns 277,550 shares of the medical instruments supplier’s stock valued at $70,742,000 after acquiring an additional 1,898 shares during the last quarter. Finally, State Street Corp lifted its stake in Mesa Laboratories by 3.3% in the first quarter. State Street Corp now owns 197,326 shares of the medical instruments supplier’s stock valued at $50,294,000 after acquiring an additional 6,249 shares during the last quarter. 92.70% of the stock is owned by hedge funds and other institutional investors.

Mesa Laboratories Price Performance

Shares of Mesa Laboratories stock opened at $178.42 on Monday. The firm has a fifty day simple moving average of $146.94 and a 200-day simple moving average of $180.47. The company has a current ratio of 2.80, a quick ratio of 2.13 and a debt-to-equity ratio of 0.53. Mesa Laboratories, Inc. has a 1-year low of $114.21 and a 1-year high of $333.42. The stock has a market capitalization of $952.23 million, a price-to-earnings ratio of -234.76 and a beta of 0.60.

Mesa Laboratories Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 15th. Stockholders of record on Wednesday, November 30th will be paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.36%. The ex-dividend date of this dividend is Tuesday, November 29th. Mesa Laboratories’s payout ratio is -84.21%.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on MLAB shares. Evercore ISI lifted their target price on shares of Mesa Laboratories to $166.00 in a research note on Tuesday, November 15th. StockNews.com upgraded shares of Mesa Laboratories from a “sell” rating to a “hold” rating in a research note on Friday, November 4th.

About Mesa Laboratories

(Get Rating)

Mesa Laboratories, Inc develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries.

Featured Articles

Want to see what other hedge funds are holding MLAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mesa Laboratories, Inc. (NASDAQ:MLABGet Rating).

Institutional Ownership by Quarter for Mesa Laboratories (NASDAQ:MLAB)

Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.